Press Release on Dialysis Therapy Research: September-2018

High rates of dementia in older adults after starting dialysis

Older adults WHO initiate chemical analysis for renal failure face the next probability of being diagnosed with dementedness and Alzheimers. bound risk factors were connected to this higher risk. Older hemodialysis patients with a identification of dementedness or Alzheimers had a high risk of early death. [1]

Takotsubo syndrome and dialysis: an uncommon association?

This review was performed to research the association between treatment with chemical analysis and Takotsubo syndrome in patients with end-stage urinary organ malady. we have a tendency to consistently explored the PubMed info exploitation the search terms “Takotsubo cardiomyopathy” and/or “stress-induced cardiomyopathy” and/or “Takotsubo syndrome” together with “dialysis” and “uremia.” Of 3630 articles found, eight articles reportage ten cases were selected for analysis. [2]

Novel extracorporeal dialysis circuit to improve the removal efficiency of high and middle molecular weight toxins

A new extracorporeal circuit for dialysis was designed with the goal of raising the center and high mass toxins removal. A recirculation pathway was adscititious to the dialysis circuit and relevant pressure regulation was performed on the circuit so as to stay the ultrafiltration rate as zero. The influence of accelerating the recirculation to dialysate flow quantitative relation to the removal of carbamide, B vitamin and hemoprotein was investigated. [3]

Effect of recombinant human erythropoietin treatment on left ventricular hypertrophy and cardiac function in dialysis patients

Background upset may be a vital complication in chronic uropathy and a significant reason behind death in chemical analysis patients. Anemia is related to reduced survival in patients with urinary organ sickness, associate degreed anemia is severally related to an enlarged risk of upset. The body adapts to anemia by increasing flow, which can lead to viscus transforming and progression of left cavum (LV) growth.

Aim The aim of this study was to shed light-weight on the results of correction of anemia once medical aid with recombinant human glycoprotein (rHuEPO) on left cavum hypertrophy (LVH) and consequently 55 perform in chemical analysis patients. So we studied 40 hemodialysis patients with hemoglobin (Hb) less than 10 g/dl as well as 10 age-matched and sex-matched hemodialysis patients with Hb more than 11 g/dl who never received erythropoietin as a control group. [4]

Screening for Fabry Disease among Dialysis Patients in Brazil: Findings from the First 18 months of a Nationwide Study

Aims: To estimate the frequency of Fabry malady (FD) among failure patients on ANalysis|qualitative analysis} in Brazil mistreatment an algorithmic rule designed to trace FD-suspected patients.

Study Design: a Cross-sectional study.

Place and length of Study: chemical analysis Centers in Brazil, from July 2013 to Dec 2014.

Methodology: a complete of twenty-five,223 chemical analysis patients from 188 chemical analysis centers unfold everywhere the country were analyzed. All collected information was entered during a information created and maintained by DataGenno Interactive Research®. AN algorithmic rule was created to kind chemical analysis patients into 3 main groups: FD-suspected patients, FD-non suspected patients, and patients for medical analysis. Further up, FD-suspected patients were submitted to GLA sequence sequencing. [5]

Reference

[1] High rates of dementia in older adults after starting dialysis

Date: August 9, 2018, Source: American Society of Nephrology (web link)

[2] Takotsubo syndrome and dialysis: an uncommon association?

Manfredini R, Fabian F, De Giorgi A, Cappadona R, Zucchi B, Storari A, Rodriguez Borrego MA, Carmona Torres JM, Lopez Soto PJ. Takotsubo syndrome and dialysis: an uncommon association?. Journal of International Medical Research. 2018 Sep:0300060518794249. (web link)

[3] A Novel extracorporeal dialysis circuit to improve the removal efficiency of high and middle molecular weight toxins

Poor Khalid A, Bizari D, Farrokhzad H. Novel extracorporeal dialysis circuit to improve the removal efficiency of high and middle molecular weight toxins. Artificial Organs. (web link)

[4] Effect of recombinant human erythropoietin treatment on left ventricular hypertrophy and cardiac function in dialysis patients

El-Badawy AM, Mansour AE, Abdelmoniem RO, Rabee AE. Effect of recombinant human erythropoietin treatment on left ventricular hypertrophy and cardiac function in dialysis patients. Journal of The Egyptian Society of Nephrology and Transplantation. 2018 Apr 1;18(2):40. (web link)

[5] Screening for Fabry Disease among Dialysis Patients in Brazil: Findings from the First 18 months of a Nationwide Study

Marcelo P. Coutinho1,2,3*, Oswaldo M. V. Neto4, Júlio C. B. Araújo2,5, Túlio M. Santos6,7, Jorge E. P. Lopez8, Luisa R. Baptista1,2, and Márcia G. Ribeiro2,3

1Campos dos Goytacazes’ Genetics Service, Campos dos Goytacazes, RJ, Brazil.

2Datagenno Interactive Research, Campos dos Goytacazes, RJ, Brazil.

3Martagão Gesteira Pediatric Institute’s Genetics Service, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.

4Department of Internal Medicine, Nephrology Service, Ribeirão Preto Medical School, São Paulo University, Ribeirão Preto, SP, Brazil.

5Computer Institute, Fluminense Federal University, Niterói, RJ, Brazil.

6Department of General Biology, Celular and Microorganisms Genetics Laboratory, Biological Sciences Institute, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.

7Uniclon Biotechnology, Belo Horizonte, MG, Brazil.

8Nephrology Service, Edmundo Vasconcelos Hospital Complex, São Paulo, SP, Brazil. (web link)

Leave a Reply

Your email address will not be published. Required fields are marked *